Discovery of an orally active VHL-recruiting PROTAC that achieves robust HMGCR degradation and potent hypolipidemic activity in vivo

Publication date: Available online 6 November 2020Source: Acta Pharmaceutica Sinica BAuthor(s): Guoshun Luo, Zhenbang Li, Xin Lin, Xinyu Li, Yu Chen, Kun Xi, Maoxu Xiao, Hanlin Wei, Lizhe Zhu, Hua Xiang
Source: Acta Pharmaceutica Sinica B - Category: Cancer & Oncology Source Type: research